Expression of TERT in early premalignant lesions and a subset of cells in normal tissues

Nature Genetics

Volumn 19, Issue 2, 1998, Pages 182-186

  Kolquist, Kathryn Ann ^a   Ellisen, Leif W ^b   Counter, Chistopher M ^c   Meyerson, Matthew ^c,d   Tan, Lee K ^a   Weinberg, Robert A ^c   Haber, Daniel A ^b   Gerald, William L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; BREAST CARCINOGENESIS; CELL IMMORTALIZATION; CELL SURVIVAL; COLON CARCINOGENESIS; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; MALIGNANT TRANSFORMATION; MITOSIS INDEX; PRIORITY JOURNAL;

BREAST NEOPLASMS; CATALYSIS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; PRECANCEROUS CONDITIONS; PROTEIN BIOSYNTHESIS; PROTEINS; RNA; RNA, MESSENGER; RNA, UNTRANSLATED; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0031809832     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/554     Document Type: Article

References (30)

1. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B. & Bacchetti, S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68, 3410-3414 (1994).
2. Kim, N.W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2013 (1994).
3. Harley, C.B. et al. Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 307-315 (1994).
4. Feng, J. et al. The RNA component of human telomerase. Science 269, 1235-1241 (1995).
5. Avilion, A.A. et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56, 645-650 (1996).
6. Blasco, M.A., Funk, W., Villeponteau, B. & Greider, C.W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267-1270 (1995).
7. Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795 (1997).
8. Nakamura, T.M. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
9. Kilian, A. et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6, 2011-2019 (1997).
10. Weinrich, S.L. et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17, 498-502 (1997).
11. Nakayama, J. et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoms. Nature Genet. 18, 65-68 (1998).
12. Counter, C. et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16, 1217-1222 (1998).
13. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
14. Shay, J.W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 (1997).
15. Harrington, L. et al. Human telomerase contains evolutionary conserved catalytic and structural subunits. Genes Dev. 11, 3109-3115 (1997).
16. Harle-Bachor, C. & Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93, 6476-6481 (1996).
17. Yasumoto, S. et al. Telomerase activity in normal human epithelial cells. Oncogene 13, 433-439 (1996).
18. Kyo, S., Takakura, M., Kohama, T. & Inoue, M. Telomerase activity in human endometrium. Cancer Res. 57, 610-614 (1997).
19. Takubo, K. et al. Telomerase activity in esophageal carcinoma. J. Surg. Oncol. 66, 88-92 (1997).
20. Fearon. E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
21. Chadeneau, C., Hay. K., Hirte, H.W., Gallinger, S. & Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533-2536 (1995).
22. Hiyama, E. et al. Telomerase activity in human intestine. Int. J. Oncol. 9, 453-458 (1996).
23. Wellings, S.R., Jensen, H.M. & Marcum, R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55, 231-273 (1975).
24. Hiyama, E. et al. Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88, 116-122 (1996).
25. Yashima, K. et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma, clin. Cancer Res. 229-234 (1998).
26. Ramakrishnan, S., Eppenberger, U., Mueller, H., Shinkai, Y. & Ramaswamy, N. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58, 622-625 (1998).
27. Greaves, M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet. 12, 127-128 (1996).
28. Belair, CD., Yeager, T.R., Lopez, P.M. & Reznikoff, C.A. Telomerase activity: A biomarker of cell proliferation not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 136677-13682 (1997).
29. Greider, C.W. Telomerase activity, cell proliferation, and cancer. Proc. Natl. Acad. Sci. USA 95, 90-92 (1998).
30. Lee. S.B. et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round cell tumour. Nature Genet. 17, 309-313 (1997).